NCT06244004View on ClinicalTrials.gov

FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial

PHASE2RecruitingINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

February 18, 2024

Primary Completion Date

February 18, 2027

Study Completion Date

February 18, 2028

Conditions
Castration-Sensitive Prostate CarcinomaMetastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
Interventions
DRUG

Antiandrogen Therapy

Undergo SOC ADT

PROCEDURE

Bone Scan

Undergo bone scan

PROCEDURE

Computed Tomography

Undergo CT

DRUG

Cytotoxic Chemotherapy

Receive SOC cytotoxic chemotherapy

PROCEDURE

FDG-Positron Emission Tomography

Undergo FDG-PET

RADIATION

Radiation Therapy

Undergo MDRT

Trial Locations (5)

60115

RECRUITING

Northwestern Medicine: Kishwaukee, DeKalb

60134

RECRUITING

Northwestern Medicine: Delnor, Geneva

60462

NOT_YET_RECRUITING

Northwestern Medicine Orland Park, Orland Park

60555

RECRUITING

Northwestern Medicine: Warrenville, Warrenville

60611

RECRUITING

Northwestern University, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER